Home › Funds › ACUTA CAPITAL PARTNERS, LLC › ACAD
ACUTA CAPITAL PARTNERS, LLC position in ACAD
ACADIA PHARMACEUTICALS INC · Health Care
ACUTA CAPITAL PARTNERS, LLC reported holding 1,000 shares of ACAD (ACADIA PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$2.0M, representing 1.59% of its reported portfolio and ranking #18 among its reported holdings. ACUTA CAPITAL PARTNERS, LLC first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How ACUTA CAPITAL PARTNERS, LLC's ACAD position evolved
ACUTA CAPITAL PARTNERS, LLC first disclosed a stake in ACAD in Q3 2026 at 1,000 shares (US$2.0M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 1.00K | $2.02M | New |
About ACAD and 13F data
ACAD (ACADIA PHARMACEUTICALS INC) is a Health Care company. 26 other funds we track also report a position in ACAD — the largest reported positions include BAKER BROS. ADVISORS LP (US$1.09B), RTW INVESTMENTS, LP (US$144.0M), Palo Alto Investors LP (US$72.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ACAD
- BAKER BROS. ADVISORS LP 42.91M sh · $1.09B · Q2 2026
- RTW INVESTMENTS, LP 7.14M sh · $143.96M · Q3 2026
- Palo Alto Investors LP 2.86M sh · $72.46M · Q2 2026
- BRAIDWELL LP 1.65M sh · $41.65M · Q2 2026
- Frazier Life Sciences Management, L.P. 1.44M sh · $36.39M · Q2 2026
More on ACUTA CAPITAL PARTNERS, LLC
FAQ
How long has ACUTA CAPITAL PARTNERS, LLC held ACAD?
ACUTA CAPITAL PARTNERS, LLC has disclosed ACAD holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is ACUTA CAPITAL PARTNERS, LLC's current position in ACAD?
As of Q3 2026, ACUTA CAPITAL PARTNERS, LLC holds 1.00K shares of ACAD (ACADIA PHARMACEUTICALS INC), valued at $2.02M, representing 1.59% of its reported portfolio and ranking #18.
Has ACUTA CAPITAL PARTNERS, LLC been buying or selling ACAD?
In the latest 13F filing (Q3 2026), ACUTA CAPITAL PARTNERS, LLC newly opened its position in ACAD.
Which other funds hold ACAD?
Other major institutional holders of ACAD include BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP, Palo Alto Investors LP, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.